BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 31201193)

  • 1. Adaptive deep brain stimulation as advanced Parkinson's disease treatment (ADAPT study): protocol for a pseudo-randomised clinical study.
    Piña-Fuentes D; Beudel M; Little S; Brown P; Oterdoom DLM; van Dijk JMC
    BMJ Open; 2019 Jun; 9(6):e029652. PubMed ID: 31201193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute effects of adaptive Deep Brain Stimulation in Parkinson's disease.
    Piña-Fuentes D; van Dijk JMC; van Zijl JC; Moes HR; van Laar T; Oterdoom DLM; Little S; Brown P; Beudel M
    Brain Stimul; 2020; 13(6):1507-1516. PubMed ID: 32738409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. At home adaptive dual target deep brain stimulation in Parkinson's disease with proportional control.
    Schmidt SL; Chowdhury AH; Mitchell KT; Peters JJ; Gao Q; Lee HJ; Genty K; Chow SC; Grill WM; Pajic M; Turner DA
    Brain; 2024 Mar; 147(3):911-922. PubMed ID: 38128546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-triggered adaptive deep brain stimulation during reaching movement in Parkinson's disease.
    He S; Baig F; Merla A; Torrecillos F; Perera A; Wiest C; Debarros J; Benjaber M; Hart MG; Ricciardi L; Morgante F; Hasegawa H; Samuel M; Edwards M; Denison T; Pogosyan A; Ashkan K; Pereira E; Tan H
    Brain; 2023 Dec; 146(12):5015-5030. PubMed ID: 37433037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind cross-over pilot trial protocol to evaluate the safety and preliminary efficacy of long-term adaptive deep brain stimulation in patients with Parkinson's disease.
    Marceglia S; Conti C; Svanidze O; Foffani G; Lozano AM; Moro E; Volkmann J; Arlotti M; Rossi L; Priori A
    BMJ Open; 2022 Jan; 12(1):e049955. PubMed ID: 34980610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease.
    Liu Y; Li W; Tan C; Liu X; Wang X; Gui Y; Qin L; Deng F; Hu C; Chen L
    J Neurosurg; 2014 Sep; 121(3):709-18. PubMed ID: 24905564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adaptive deep brain stimulation for Parkinson's disease: looking back at the past decade on motor outcomes.
    An Q; Yin Z; Ma R; Fan H; Xu Y; Gan Y; Gao Y; Meng F; Yang A; Jiang Y; Zhu G; Zhang J
    J Neurol; 2023 Mar; 270(3):1371-1387. PubMed ID: 36471098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early versus Late Application of Subthalamic deep brain Stimulation to Parkinson's disease patients with motor complications (ELASS): protocol of a multicentre, prospective and observational study.
    Jiang L; Poon WS; Moro E; Xian W; Yang C; Zhu XL; Gu J; Cai X; Liu J; Mok V; Liu Y; Xu S; Guo Q; Chen W; Chen L
    BMJ Open; 2017 Nov; 7(11):e018610. PubMed ID: 29150478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On-Off and Proportional Closed-Loop Adaptive Deep Brain Stimulation Reduces Motor Symptoms in Freely Moving Hemiparkinsonian Rats.
    Evers J; Orłowski J; Jahns H; Lowery MM
    Neuromodulation; 2024 Apr; 27(3):476-488. PubMed ID: 37245140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The characteristics of pallidal low-frequency and beta bursts could help implementing adaptive brain stimulation in the parkinsonian and dystonic internal globus pallidus.
    Piña-Fuentes D; van Zijl JC; van Dijk JMC; Little S; Tinkhauser G; Oterdoom DLM; Tijssen MAJ; Beudel M
    Neurobiol Dis; 2019 Jan; 121():47-57. PubMed ID: 30227227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson's disease.
    Ostrem JL; Ziman N; Galifianakis NB; Starr PA; Luciano MS; Katz M; Racine CA; Martin AJ; Markun LC; Larson PS
    J Neurosurg; 2016 Apr; 124(4):908-16. PubMed ID: 26495947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial.
    Odekerken VJ; van Laar T; Staal MJ; Mosch A; Hoffmann CF; Nijssen PC; Beute GN; van Vugt JP; Lenders MW; Contarino MF; Mink MS; Bour LJ; van den Munckhof P; Schmand BA; de Haan RJ; Schuurman PR; de Bie RM
    Lancet Neurol; 2013 Jan; 12(1):37-44. PubMed ID: 23168021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on Subthalamic Nucleus and Globus Pallidus Internus Deep Brain Stimulation for the Treatment of Patients With Parkinson's Disease: Executive Summary.
    Rughani A; Schwalb JM; Sidiropoulos C; Pilitsis J; Ramirez-Zamora A; Sweet JA; Mittal S; Espay AJ; Martinez JG; Abosch A; Eskandar E; Gross R; Alterman R; Hamani C
    Neurosurgery; 2018 Jun; 82(6):753-756. PubMed ID: 29538685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkinson's disease outcomes after intraoperative CT-guided "asleep" deep brain stimulation in the globus pallidus internus.
    Mirzadeh Z; Chapple K; Lambert M; Evidente VG; Mahant P; Ospina MC; Samanta J; Moguel-Cobos G; Salins N; Lieberman A; Tröster AI; Dhall R; Ponce FA
    J Neurosurg; 2016 Apr; 124(4):902-7. PubMed ID: 26452116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bilateral adaptive deep brain stimulation is effective in Parkinson's disease.
    Little S; Beudel M; Zrinzo L; Foltynie T; Limousin P; Hariz M; Neal S; Cheeran B; Cagnan H; Gratwicke J; Aziz TZ; Pogosyan A; Brown P
    J Neurol Neurosurg Psychiatry; 2016 Jul; 87(7):717-21. PubMed ID: 26424898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eight-hours conventional versus adaptive deep brain stimulation of the subthalamic nucleus in Parkinson's disease.
    Bocci T; Prenassi M; Arlotti M; Cogiamanian FM; Borellini L; Moro E; Lozano AM; Volkmann J; Barbieri S; Priori A; Marceglia S
    NPJ Parkinsons Dis; 2021 Sep; 7(1):88. PubMed ID: 34584095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single threshold adaptive deep brain stimulation in Parkinson's disease depends on parameter selection, movement state and controllability of subthalamic beta activity.
    Busch JL; Kaplan J; Habets JGV; Feldmann LK; Roediger J; Köhler RM; Merk T; Faust K; Schneider GH; Bergman H; Neumann WJ; Kühn AA
    Brain Stimul; 2024; 17(1):125-133. PubMed ID: 38266773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Directional versus ring-mode deep brain stimulation for Parkinson's disease: protocol of a multi-centre double-blind randomised crossover trial.
    Brinke TRT; Jergas H; Sisodia V; Barbe MT; Odekerken VJJ; Verbaan D; Dijk JM; Bot M; Beudel M; van den Munckhof P; Schuurman PR; de Bie RMA
    BMC Neurol; 2023 Oct; 23(1):372. PubMed ID: 37853327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Rescue" of bilateral subthalamic stimulation by bilateral pallidal stimulation: case report.
    Matias CM; Silva D; Machado AG; Cooper SE
    J Neurosurg; 2016 Feb; 124(2):417-21. PubMed ID: 26230477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.